CXCL12 rs1801157 polymorphism and expression in peripheral blood from breast cancer patients

Cytokine

Volumn 55, Issue 2, 2011, Pages 260-265

  De Oliveira, Karen Brajão ^a   Guembarovski, Roberta Losi ^a   Oda, Julie Massayo Maeda ^a   Mantovani, Mário Sérgio ^a   Carrera, Clisia Mara ^a   Vissoci Reiche, Edna Maria ^a   Voltarelli, Julio Cesar ^b   Da Silva do Amaral Herrera, Ana Cristina ^a,c   Watanabe, Maria Angelica Ehara ^a  

^a STATE UNIVERSITY OF LONDRINA   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c Cancer Hospital of Londrina   (Brazil)

Author keywords

Breast cancer; CXCL12 rs1801157 polymorphism; Estrogen receptor

Indexed keywords

ALANINE; CHEMOKINE RECEPTOR CXCR4; ESTROGEN; GLYCINE; MESSENGER RNA; STROMAL CELL DERIVED FACTOR 1;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER STAGING; CONTROLLED STUDY; FEMALE; GENE EXPRESSION PROFILING; GENE FREQUENCY; GENETIC DIFFERENCE; GENOTYPE; HUMAN; LEUKOCYTE MIGRATION; MAJOR CLINICAL STUDY; METASTASIS; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SINGLE NUCLEOTIDE POLYMORPHISM; TUMOR GENE; TUMOR GROWTH; TUMOR VASCULARIZATION;

ALLELES; BREAST NEOPLASMS; CHEMOKINE CXCL12; FEMALE; GENOTYPE; HUMANS; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, CXCR4; RNA, MESSENGER; TREATMENT OUTCOME;

EID: 79959543353     PISSN: 10434666     EISSN: 10960023     Source Type: Journal    
DOI: 10.1016/j.cyto.2011.04.017     Document Type: Article

References (60)

1. Jemal A., Bray F., Center M.M., Ferlay J., Ward E., Forman D. Global cancer statistics. CA Cancer J Clin 2011, 61:69-90.
2. Brasil, Ministério da Saúde, Instituto Nacional de Câncer, Estimativa 2010: incidência de câncer no Brasil/Instituto Nacional de Câncer - Rio de Janeiro, INCA, 2009, p. 98.
3. Muller A., Homey B., Soto H., Ge N., Catron D., Buchanan M.E., et al. Involvement of chemokine receptors in breast cancer metastasis. Nature 2001, 410:50-56.
4. Tashiro K., Tada H., Heilker R., Shirozu M., Nakano T., Honjo T. Signal sequence trap: a cloning strategy for secreted proteins and type I membrane proteins. Science 1993, 261:600-603.
5. Nagasawa T., Hirota S., Tachibana K., Takakura N., Nishikawa S., Kitamura Y., et al. Defects of B-cell lymphopoiesis and bone-marrow myelopoiesis in mice lacking the CXC chemokine PBSF/SDF-1. Nature 1996, 382:635-638.
6. Askari A.T., Unzek S., Popovic Z.B., Goldman C.K., Forudi F., Kiedrowski M., et al. Effect of stromal-cell-derived factor 1 on stem-cell homing and tissue regeneration in ischaemic cardiomyopathy. Lancet 2003, 362:697-703.
7. Ratajczak M.Z., Majka M., Kucia M., Drukala J., Pietrzkowski Z., Peiper S., et al. Expression of functional CXCR4 by muscle satellite cells and secretion of SDF-1 by muscle-derived fibroblasts is associated with the presence of both muscle progenitors in bone marrow and hematopoietic stem/progenitor cells in muscles. Stem Cells 2003, 21:363-371.
8. Kollet O., Shivtiel S., Chen Y.Q., Suriawinata J., Thung S.N., Dabeva M.D., et al. HGF, SDF-1, and MMP-9 are involved in stress-induced human CD34+ stem cell recruitment to the liver. J Clin Investig 2003, 112:160-169.
9. Tachibana K., Hirota S., Iizasa H., Yoshida H., Kawabata K., Kataoka Y., et al. The chemokine receptor CXCR4 is essential for vascularization of the gastrointestinal tract. Nature 1998, 393:591-594.
10. Schrader A.J., Lechner O., Templin M., Dittmar K.E., Machtens S., Mengel M., et al. CXCR4/CXCL12 expression and signaling in kidney cancer. Br J Cancer 2002, 86:1250-1256.
11. Ponomaryov T., Peled A., Petit I., Taichman R.S., Habler L., Sandbank J., et al. Induction of the chemokine stromal-derived factor-1 following DNA damage improves human stem cell function. J Clin Investig 2000, 106:1331-1339.
12. Yun H.J., Jo D.Y. Production of stromal cell-derived factor-1 (SDF-1) and expression of CXCR4 in human bone marrow endothelial cells. J Korean Med Sci 2003, 18:679-685.
13. Ma Q., Jones D., Borghesani P.R., Segal R.A., Nagasawa T., Kishimoto T., et al. Impaired B-lymphopoiesis, myelopoiesis, and derailed cerebellar neuron migration in CXCR4- and SDF-1-deficient mice. Proc Natl Acad Sci USA 1998, 95:9448-9453.
14. Barbieri F., Bajetto A., Porcile C., Pattarozzi A., Massa A., Lunardi G., et al. CXC receptor and chemokine expression in human meningioma: SDF1/CXCR4 signaling activates ERK1/2 and stimulates meningioma cell proliferation. Ann NY Acad Sci 2006, 1090:332-343.
15. Hattori K., Heissig B., Tashiro K., Honjo T., Tateno M., Shieh J.H., et al. Plasma elevation of stromal cell derived factor-1 induces mobilization of mature and immature hematopoietic progenitor and stem cells. Blood 2001, 97:3354-3360.
16. Lane W.J., Dias S., Hattori K., Heissig B., Choy M., Rabbany S.Y., et al. Stromal-derived factor 1-induced megakaryocyte migration and platelet production is dependent on matrix metalloproteinases. Blood 2000, 96:4152-4159.
17. Petit I., Jin D., Rafii S. The SDF-1-CXCR4 signaling pathway: a molecular hub modulating neo-angiogenesis. Trends Immunol 2007, 28:299-307.
18. Burger J.A., Kipps T.J. CXCR4: a key receptor in the crosstalk between tumor cells and their microenvironment. Blood 2006, 107:1761-1767.
19. Kakinuma T., Hwang S.T. Chemokines, chemokine receptors, and cancer metastasis. J Leukoc Biol 2006, 79:639-651.
20. Kulbe H., Levinson N.R., Balkwill F., Wilson J.L. The chemokine network in cancer-much more than directing cell movement. Int J Dev Biol 2004, 48:489-496.
21. Kobayashi T., Tsuda H., Moriya T., Yamasaki T., Kikuchi R., Ueda S., et al. Expression pattern of stromal cell-derived factor-1 chemokine in invasive breast cancer is correlated with estrogen receptor status and patient prognosis. Breast Cancer Res Treat 2010, 123:733-745.
22. Haribabu B., Richardson R.M., Fisher I., Sozzani S., Peiper S.C., Horuk R., et al. Regulation of human chemokine receptors CXCR4. Role of phosphorylation in desensitization and internalization. J Biol Chem 1997, 272:28726-28731.
23. Fischer T., Nagel F., Jacobs S., Stumm R., Schulz S. Reassessment of CXCR4 chemokine receptor expression in human normal and neoplastic tissues using the novel rabbit monoclonal antibody UMB-2. PLoS One 2008, 3:e4069.
24. Hassan S., Baccarelli A., Salvucci O., Basik M. Plasma stromal cell-derived factor-1: host derived marker predictive of distant metastasis in breast cancer. Clin Cancer Res 2008, 14:446-454.
25. Oliveira K.B., Oda J.M.M., Nasser T.F., Fujita T.C., Matsuo T., Ono M.A., et al. CXCL12 rs1801157 polymorphism in patients with breast cancer, Hodgkin's lymphoma and non-Hodgkin's lymphoma. J Clin Lab Anal 2009, 23:387-393.
26. Oliveira C.E.C., Cavassin G.G.O., Perim A.L., Nasser T.F., Oliveira K.B., Fungaro M.H.P., et al. Stromal cell-derived factor-1 chemokine gene variant in blood donors and chronic myelogenous leukemia patients. J Clin Lab Anal 2007, 21:49-54.
27. Cavassin G.G.O., De Lucca F.L., Delgado André N., Covas D.T., Pelegrinelli Fungaro M.H., Voltarelli J.C., et al. Molecular investigation of the stromal cell-derived factor-1 chemokine in lymphoid leukemia and lymphoma patients from Brazil. Blood Cells Mol Dis 2004, 33:90-93.
28. Kirby L.T. DNA fingerprinting: an introduction 1990, Stocton Press, New York.
29. Amarante M.K., De Lucca F.L., Oliveira C.E.C., Pelegrinelli Fungaro M.E., Reiche E.M., Muxel S.M., et al. Expression of noncoding mRNA in human blood cells activated with synthetic peptide of HIV. Blood Cells Mol Dis 2005, 35:286-290.
30. Pfaffl M.W. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 2001, 29:e45.
31. Dapic V., Carvalho M.A., Monteiro A.N. Breast cancer susceptibility and the DNA damage response. Cancer Control 2005, 12:127-136.
32. Veronesi U., Boyle P., Goldhirsch A., Orecchia R., Viale G. Breast cancer. Lancet 2005, 365:1727-1741.
33. Vargo-Gogola T., Rosen J.M. Modelling breast cancer: one size does not fit all. Nat Rev Cancer 2007, 7:659-672.
34. Fulop T., Kotb R., Fortin C.F., Pawelec G., de Angelis F., Larbi A. Potential role of immunosenescence in cancer development. Ann NY Acad Sci 2010, 1197:158-165.
35. Malaguarnera L., Cristaldi E., Malaguarnera M. The role of immunity in elderly cancer. Crit Rev Oncol Hematol 2010, 74:40-60.
36. Hasty P., Campisi J., Hoeijmakers J., van Steeg H., Vijg J. Ageing and genome maintenance: lessons from the mouse?. Science 2003, 299:1355-1359.
37. Kirkwood T.B., Austad S.N. Why do we age?. Nature 2000, 408:233-238.
38. Finkel T., Serrano M., Blasco M.A. The common biology of cancer and ageing. Nature 2007, 448:767-774.
39. Ben-Baruch A. The multifaceted roles of chemokines in malignancy. Cancer Metastasis Rev 2006, 25:357-371.
40. Lacroix M. Significance, detection and markers of disseminated breast cancer cells. Endocr Relat Cancer 2006, 13:1033-1067.
41. Kruszyna L., Lianeri M., Rubis B., Knuła H., Rybczyńska M., Grodecka-Gazdecka S., et al. CXCL12-3' G801A polymorphism is not a risk factor for breast cancer. DNA Cell Biol 2010, 29:423-427.
42. Zafiropoulos A., Crikas N., Passam A.M., Spandidos D.A. Significant involvement of CCR2-64I and CXCL12-3a in the development of sporadic breast cancer. J Med Genet 2004, 41:1-5.
43. Razmkhah M., Talei A.R., Doroudchi M., Khalili-Azad T., Ghaderi A. Stromal cell-derived factor-1 (SDF-1) alleles and susceptibility to breast carcinoma. Cancer Lett 2005, 225:261-266.
44. Pemberton N.C., Paneesha S., Hiller L., Starczynski J., Hooper L., Pepper C., et al. The SDF-1 G>A polymorphismat position 801 plays no role in multiplemyeloma but may contribute to an inferior cause-specific survival in chronic lymphocytic leukemia. Leuk Lymphoma 2006, 47:1239-1244.
45. Dimberg J., Hugander A., Löfgren S., Wågsäter D. Polymorphism and circulating levels of the chemokine CXCL12 in colorectal cancer patients. Int J Mol Med 2007, 19:11-15.
46. Maley S.N., Schwartz S.M., Johnson L.G., Malkki M., Du Q., Daling J.R., et al. Genetic variation in CXCL12 and risk of cervical carcinoma: a population-based case-control study. Int J Immunogenet 2009, 36:367-375.
47. Vázquez-Lavista L.G., Lima G., Gabilondo F., Llorente L. Genetic association of monocyte chemoattractant protein 1 (MCP-1)-2518 polymorphism in Mexican patients with transitional cell carcinoma of the bladder. Urology 2009, 74:414-418.
48. Baggiolini M. Chemokines in pathology and medicine. J Intern Med 2001, 250:91-104.
49. Winkler C., Modi W., Smith M.W., Nelson G.W., Wu X., Carrington M., et al. Genetic restriction of AIDS pathogenesis by an SDF-1 chemokine gene variant. ALIVE Study, Hemophilia Growth and Development Study (HGDS), Multicenter AIDS Cohort Study (MACS), Multicenter Hemophilia Cohort Study (MHCS), San Francisco City Cohort (SFCC). Science 1998, 279:389-393.
50. Kimura R., Nishioka T., Ishida T. The SDF1-G801A polymorphism is not associated with SDF1 gene expression in Epstein-Barr virus-transformed lymphoblastoid cells. Genes Immun 2003, 4:356-361.
51. Watanabe M.A., De Oliveira Cavassin G.G., Orellana M.D., Milanezi C.M., Voltarelli J.C., Kashima S., et al. SDF-1 gene polymorphisms and syncytia induction in Brazilian HIV-1 infected individuals. Microb Pathog 2003, 35:31-34.
52. Chang S.C., Lin P.C., Yang S.H., Wang H.S., Li A.F., Lin J.K. SDF-1alpha G801A polymorphism predicts lymph node metastasis in stage T3 colorectal cancer. Ann Surg Oncol 2009, 16:2323-2330.
53. Garcia-Moruja C., Rueda P., Torres C., Alcami J., Luque F., Caruz A. Molecular phenotype of CXCL12beta 3'UTR G801A polymorphism (rs1801157) associated to HIV-1 disease progression. Curr HIV Res 2009, 7:384-389.
54. Sei S., O'Neill D.P., StewartK S.K., Yang Q., Kumagai M., Boler A.M., et al. Increased level of stromal cell-derived factor-1mRNA in peripheral blood mononuclear cells from children with AIDS-related lymphoma. Cancer Res 2001, 61:5028-5037.
55. Mirisola V., Zuccarino A., Bachmeier B.E., Sormani M.P., Falter J., Nerlich A., et al. CXCL12/SDF1 expression by breast cancers is an independent prognostic marker of disease-free and overall survival. Eur J Cancer 2009, 45:2579-2587.
56. Thakkar J.P., Mehta D.G. A review of an unfavorable subset of breast cancer: estrogen receptor positive progesterone receptor negative. Oncologist 2011, 16:276-285.
57. Ciocca D.R., Elledge R. Molecular markers for predicting response to tamoxifen in breast cancer patients. Endocrine 2000, 13:1-10.
58. Hall J.M., Korach K.S. Stromal cell-derived factor 1, a novel target of estrogen receptor action, mediates the mitogenic effects of estradiol in ovarian and breast cancer cells. Mol Endocrinol 2003, 17:792-803.
59. Habauzit D., Boudot A., Kerdivel G., Flouriot G., Pakdel F. Development and validation of a test for environmental estrogens: checking xeno-estrogen activity by CXCL12 secretion in breast cancer cell lines (CXCL-test). Environ Toxicol 2010, 25:495-503.
60. Sauvé K., Lepage J., Sanchez M., Heveker N., Tremblay A. Positive feedback activation of estrogen receptors by the CXCL12-CXCR4 pathway. Cancer Res 2009, 69:5793-5800.